 |
|
Graves’ disease: an uncommon cause of late sequelae following DRESS (drug reaction with eosinophilia and systemic symptoms)
Therdpong Tempark, Amatanun Tangthanapalakul, Tawatchai Deekajorndech, Susheera Chatproedprai, Vichit Supornsilchai, Siriwan Wananukul
Clin Exp Pediatr. 2022;65(12):602-604. Published online 2022 Jun 22 DOI: https://doi.org/10.3345/cep.2022.00381
|
|
Citations to this article as recorded by
 Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis
Brian M. Wei, Lindy P. Fox, Benjamin H. Kaffenberger, Abraham M. Korman, Robert G. Micheletti, Arash Mostaghimi, Megan H. Noe, Misha Rosenbach, Kanade Shinkai, Jason H. Kwah, Elizabeth J. Phillips, Jean L. Bolognia, William Damsky, Caroline A. Nelson
Journal of the American Academy of Dermatology.2024; 90(5): 885. CrossRef Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review
Nicole Cherepacha, Frances St George-Hyslop, Bindiya Chugani, Yousef Alabdeen, Luis F. Sanchez-Espino, Quenby Mahood, Cathryn Sibbald, Ruud H. J. Verstegen
American Journal of Clinical Dermatology.2024;[Epub] CrossRef Allopurinol
Reactions Weekly.2023; 1940(1): 22. CrossRef
|